170 related articles for article (PubMed ID: 11389494)
1. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea.
Cheong HJ; Yoo CW; Sohn JW; Kim WJ; Kim MJ; Park SC
Clin Infect Dis; 2001 Jul; 33(1):48-53. PubMed ID: 11389494
[TBL] [Abstract][Full Text] [Related]
2. Emergence and dissemination of quinolone-resistant Escherichia coli in the community.
Garau J; Xercavins M; Rodríguez-Carballeira M; Gómez-Vera JR; Coll I; Vidal D; Llovet T; Ruíz-Bremón A
Antimicrob Agents Chemother; 1999 Nov; 43(11):2736-41. PubMed ID: 10543756
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection.
Eom JS; Hwang BY; Sohn JW; Kim WJ; Kim MJ; Park SC; Cheong HJ
Microb Drug Resist; 2002; 8(3):227-34. PubMed ID: 12363013
[TBL] [Abstract][Full Text] [Related]
4. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections.
Velasco M; Horcajada JP; Mensa J; Moreno-Martinez A; Vila J; Martinez JA; Ruiz J; Barranco M; Roig G; Soriano E
Clin Infect Dis; 2001 Nov; 33(10):1682-6. PubMed ID: 11595990
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin-resistant Escherichia coli from bacteraemias in England; increasingly prevalent and mostly from men.
Livermore DM; Nichols T; Lamagni TL; Potz N; Reynolds R; Duckworth G
J Antimicrob Chemother; 2003 Dec; 52(6):1040-2. PubMed ID: 14585850
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology of multi-resistant Escherichia coli.
Guyot A; Barrett SP; Threlfall EJ; Hampton MD; Cheasty T
J Hosp Infect; 1999 Sep; 43(1):39-48. PubMed ID: 10462638
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli.
Colodner R; Kometiani I; Chazan B; Raz R
Infection; 2008 Feb; 36(1):41-5. PubMed ID: 18193386
[TBL] [Abstract][Full Text] [Related]
8. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
[TBL] [Abstract][Full Text] [Related]
9. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting.
Gottesman BS; Carmeli Y; Shitrit P; Chowers M
Clin Infect Dis; 2009 Sep; 49(6):869-75. PubMed ID: 19686074
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
[TBL] [Abstract][Full Text] [Related]
11. Multidrug-resistant Escherichia coli clonal groups causing community-acquired bloodstream infections.
Manges AR; Perdreau-Remington F; Solberg O; Riley LW
J Infect; 2006 Jul; 53(1):25-9. PubMed ID: 16269177
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Lautenbach E; Strom BL; Bilker WB; Patel JB; Edelstein PH; Fishman NO
Clin Infect Dis; 2001 Oct; 33(8):1288-94. PubMed ID: 11565067
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant Escherichia coli bacteremia in cancer patients.
Vigil KJ; Adachi JA; Aboufaycal H; Hachem RY; Reitzel RA; Jiang Y; Tarrand JJ; Chemaly RF; Bodey GP; Rolston KV; Raad I
Am J Infect Control; 2009 Nov; 37(9):741-5. PubMed ID: 19487050
[TBL] [Abstract][Full Text] [Related]
15. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.
Bolon MK; Wright SB; Gold HS; Carmeli Y
Antimicrob Agents Chemother; 2004 Jun; 48(6):1934-40. PubMed ID: 15155181
[TBL] [Abstract][Full Text] [Related]
16. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region.
Laupland KB; Gregson DB; Church DL; Ross T; Pitout JD
Clin Microbiol Infect; 2008 Nov; 14(11):1041-7. PubMed ID: 19040476
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection.
Killgore KM; March KL; Guglielmo BJ
Ann Pharmacother; 2004; 38(7-8):1148-52. PubMed ID: 15150380
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiological aspects of ciprofloxacin-resistant Escherichia coli at a general hospital].
Serrano FJ; Muñoz RM; Vidal SS; Morán FG; García CB; Aznar AB
Rev Esp Quimioter; 2000 Mar; 13(1):44-50. PubMed ID: 10855024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
